Evidence map›Paper›PMID 34835485›Full record

ArticleMicroorganisms2021

Impact of O-Acetylation on

Vanessa Arato, Davide Oldrini, Luisa Massai, Gianmarco Gasperini, Francesca Necchi, Francesca Micoli

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Development of a NovelVaccines · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vanessa AratoGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Davide OldriniGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Luisa MassaiGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Gianmarco GasperiniGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Francesca NecchiGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Francesca MicoliGSK Vaccines Institute for Global Health, 53100 Siena, Italy.
Toscana Life Sciences · IT

Funding

U.K. Department of Health and Social Care EP/R013764/1
6 · The paper itself

Abstract

Shigellosis is a diarrheal disease caused prevalently by

Indexed as

GMMA vaccineO-acetylationO-antigenShigella flexneri

Identifiers

PMID34835485
PMCPMC8623282
OpenAlexW3212648759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.